IRWD
NASDAQ · Biotechnology
Ironwood Pharmaceuticals Inc
$4.03
+0.26 (+6.90%)
Open$4.30
Previous Close$3.77
Day High$4.41
Day Low$3.84
52W High$5.78
52W Low$1.76
Volume—
Avg Volume1.52M
Market Cap665.92M
P/E Ratio5.13
EPS$0.76
SectorBiotechnology
Analyst Ratings
Buy
10 analysts
Price Target
+1,182.9% upside
Current
$4.03
$4.03
Target
$51.70
$51.70
$40.79
$51.70 avg
$62.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 300.26M | 334.81M | 73.58M |
| Net Income | 24.36M | 24.44M | 12.49M |
| Profit Margin | 8.1% | 7.7% | 17.0% |
| EBITDA | 101.77M | 107.81M | 23.02M |
| Free Cash Flow | — | — | 13.98M |
| Rev Growth | -10.3% | -10.3% | +11.9% |
| Debt/Equity | 0.61 | 0.61 | 0.47 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |